Colossal Biosciences, the Dallas-based de-extinction company, has announced a significant advancement in its effort to resurrect the dodo. The firm's Avian Genetics Group has successfully grown primordial germ cells (PGCs) from a pigeon, marking a critical step in the species' revival. This breakthrough is the first time PGCs have been successfully cultured for a bird outside of chickens and geese, a development that could revolutionize avian reproductive science.
The scientific milestone coincides with a substantial financial boost for the company. Colossal has secured an additional $120 million in new funding. This latest capital infusion places the company's valuation at an impressive $10.32 billion, with total funding since its 2021 inception now exceeding $555 million.
